HS mimetics are an emerging class of antitumor drugs characterized by a complex mechanism of action based on interference with both heparanase and HSPGs’ functions, thereby potentially affecting tumor deregulated and microenvironment-dependent pathways [83]. This evidence concerns the gene HPSE and neoplasm.